Why Do My BD Micro-Fine Syringes Arrive in Embecta Packaging?
, by Charles Medical, 3 min reading time
Ordered BD Micro-Fine insulin syringes and received a box branded Embecta? You have received the correct product. In April 2022, BD (Becton, Dickinson and Company) spun off its Diabetes Care division into a new independent company called Embecta. The BD Micro-Fine syringe range transferred as part of this transition. The products remain identical in specification, quality, and clinical performance — only the packaging branding has changed.
If you've recently ordered BD Micro-Fine insulin syringes or pen needles and noticed that the box says Embecta instead of BD, you're not alone.
This is one of the most common questions we receive from customers, healthcare professionals, clinics, and patients. The good news is that there has been no change to the product itself. The difference is simply the branding displayed on the packaging.
The Short Answer
BD (Becton, Dickinson and Company) separated its Diabetes Care business into a new independent company called Embecta in April 2022.
As a result, insulin syringes and pen needles that were previously supplied in BD-branded packaging are now supplied in Embecta-branded packaging.
The products themselves remain the same trusted insulin syringes and pen needles that customers have used for many years.
What Happened to BD Diabetes Care?
On 1 April 2022, BD completed the spin-off of its Diabetes Care division, creating a new publicly traded company called Embecta.
The purpose of the separation was to allow both businesses to focus on their respective specialist healthcare markets.
Following the transition:
- BD continued operating its core medical technology, diagnostics, and life sciences businesses.
- Embecta became a dedicated diabetes management company.
- Products previously sold under the BD Diabetes Care brand transitioned to Embecta branding.
This change affected many familiar products, including the popular BD Micro-Fine insulin syringe range.
Are BD Micro-Fine Syringes Still the Same Product?
Yes.
The BD Micro-Fine insulin syringes and pen needles continue to be manufactured to the same specifications, quality standards, and performance requirements associated with the BD Micro-Fine range.
Customers can expect:
- The same needle gauge and length
- The same dosing accuracy
- The same sterile single-use design
- The same clinical performance
- The same quality standards
The primary change is the branding displayed on the outer packaging.
Why Does the Box Say Embecta?
Embecta is now responsible for the former BD Diabetes Care product portfolio.
As a result, insulin syringes and pen needles that were historically supplied in BD-branded boxes are now supplied in Embecta-branded packaging.
Many customers still refer to these products as “BD Micro-Fine syringes” because that product name remains widely recognised throughout healthcare settings.
Why Does Charles Medical Advertise BD Micro-Fine Syringes?
Healthcare professionals, clinics, pharmacies, and patients across the UK continue to search for BD Micro-Fine syringes when purchasing insulin administration products.
To help customers find the correct product, we continue to reference the well-known BD Micro-Fine product range whilst clearly explaining that products may be supplied in Embecta-branded packaging.
Our aim is to ensure customers receive the correct product whilst avoiding confusion caused by the branding transition.
Frequently Asked Questions
Have I received the wrong product?
No. If your order was for BD Micro-Fine insulin syringes and the box displays the Embecta brand, you have received the correct product.
Has the manufacturer changed?
No. The needles remain part of the BD Micro-Fine product range and continue to be manufactured to the same BD specifications and quality standards. The change is a corporate and branding transition only — not a change in manufacturing or product composition.
Have the specifications changed?
No. The needle size, syringe capacity, graduations, sterility, and intended use remain unchanged.
Why are some suppliers showing BD and others showing Embecta?
The healthcare industry continues to recognise the BD Micro-Fine product range, whilst newer stock is supplied in Embecta-branded packaging. As a result, both names are commonly referenced within the market.
Buy With Confidence
At Charles Medical, we understand that changes in branding can cause confusion, particularly when purchasing products that are used daily in clinical practice or for personal healthcare needs.
When purchasing BD Micro-Fine insulin syringes from Charles Medical, you can be confident that:
- You are receiving genuine products from the BD Diabetes Care product range.
- Products may be supplied in Embecta-branded packaging.
- Product specifications and performance remain consistent with the recognised BD Micro-Fine range.
- Every product is supplied sterile and suitable for its intended use.
If you have any questions about BD Micro-Fine syringes, Embecta packaging, or product compatibility, our team is always happy to help.